Análisis Argos
DOC
DOCEn su precio1 señal de riesgo
Healthpeak Properties, Inc. · Real Estate
US$ 21.89
precio al 2026-07-04
Valor justo Argos*
US$ 20–22
vs. su valor justo
1% por encima
Score Argos
30/100
En su precio
LA RESPUESTA
El precio asume un crecimiento (4.2%) en línea con lo que la empresa demuestra (2.4%). Ni ganga ni exceso — el mercado le puso un precio razonable.
Recompensas
Reparte dividendo sostenible (5.57%).
Riesgos
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
!Altman Z'' en zona roja (-0.09)
VALOR3/6FUTURO2/6PASADO1/6SALUD1/6DIVIDENDO5/6
El Iris de calidad
VALOR3/6FUTURO2/6PASADO1/6SALUD1/6DIVIDENDO5/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial débil
SaludBalance frágil
DividendoDevuelve capital al accionista
Score Argos30de 100En su precio
Ingresos4%
US$ 2.8 B
Margen operativo11%
19.3%
Flujo de caja libre17%
US$ 1.3 B
Deuda neta
US$ 9.9 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 15.1B
P/E211.5x
EV/EBITDA15.6x
FCF yield8.3%
ROIC2.9%
Margen operativo19.3%
Crecim. ingresos+4.5%/año
Piotroski F4/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

247wallst.com · 3 jul
3 REITs to Buy for Passive Income in July
Income investors entering July 2026 are getting a friendlier setup than they had six months ago.
zacks.com · 26 jun
Healthpeak Properties Gains 28% in 3 Months: Will the Trend Last?
DOC surges 28% in three months as leasing, occupancy gains and Janus Living growth support its shift toward labs and outpatient assets.
247wallst.com · 24 jun
5 High-Yielding S&P 500 Stocks Trading at Double-Digit Discounts Are Incredible Strong Buys Now
The Standard and Poor's 500 is a stock market index that tracks the performance of the 500 biggest companies in the United States. It is considered a top indicator of the U.S. stock market's health. It is a market-capitalization-weighted index of the 500 leading publicly traded companies in the U.S. Typically, larger companies significantly impact... 5 High-Yielding S&P 500 Stocks Trading at Double-Digit Discounts Are Incredible Strong Buys Now
seekingalpha.com · 19 jun
Healthpeak Properties: This 6% Yielding REIT Has More Room To Run
Healthpeak Properties remains a Strong Buy, combining value, income, and recovery potential in healthcare real estate. DOC's outpatient medical and life sciences segments show improving occupancy, strong lease spreads, and embedded rent escalators supporting steady growth. The Janus Living spin-off unlocks value in senior housing, with DOC retaining 82% ownership and benefiting from high segment growth.
businesswire.com · 18 jun
Healthpeak Properties Publishes Its 15th Annual Corporate Impact Report
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. ("Healthpeak") (NYSE: DOC) announced today the release of its 15th annual 2025 Corporate Impact Report (the "Report"). The Report highlights Healthpeak's continued focus on building a resilient portfolio, advancing sustainability goals, fostering a workplace culture guided by its WE CARE core values, and promoting sound corporate governance and transparency. "As one of the nation's leading owners of Outpatient Medical, Lab, and Senior Housing.
businesswire.com · 15 jun
Healthpeak Properties Announces Dates of Second Quarter 2026 Earnings Release, Conference Call, and Webcast
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report second quarter 2026 financial results after the close of trading on the New York Stock Exchange on Tuesday, August 4, 2026. Healthpeak will host a conference call and webcast on Wednesday, August 5, 2026 at 10:00 a.m. Eastern Time to review its financial performance and operating results. The conference call can b.
seekingalpha.com · 7 jun
Alexandria Or Healthpeak? Your Risk Tolerance May Determine The Winner
Healthpeak Properties offers a diversified, growth-oriented REIT portfolio with 40% life science exposure and robust 2026 FFO guidance of $1.71–$1.75 per share. DOC maintains conservative 37.3% leverage, investment-grade ratings with a stable outlook, and a well-covered 6.2% monthly dividend supported by a 70% payout ratio. Alexandria Real Estate is in portfolio contraction mode, facing sector oversupply and negative re-leasing spreads, with 2026 FFO guidance annualized at $5.80 per share.
zacks.com · 4 jun
Healthpeak (DOC) Down 2.2% Since Last Earnings Report: Can It Rebound?
Healthpeak (DOC) reported earnings 30 days ago. What's next for the stock?

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.